Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

CHARACTERIZATION OF MODERATE AND SEVERE ASTHMA EXACERBATIONS IN THE CAPTAIN STUDY.

Journal article

Oppenheimer J. et al, (2024), J Allergy Clin Immunol Pract

Blood eosinophils and lung function loss: from passive prediction to active prevention?

Journal article

Ramakrishnan S. et al, (2024), European Respiratory Journal, 63, 2400812 - 2400812

The Rebirth of Lebrikizumab for Airway Disease.

Journal article

Pavord ID., (2024), J Allergy Clin Immunol Pract, 12, 1225 - 1227

Dupilumab sustains lung function improvements in patients with moderate-to-severe asthma.

Journal article

Papi A. et al, (2024), Respiratory medicine, 224

Dupilumab reduces exacerbations independent of changes in biomarkers in moderate-to-severe asthma.

Journal article

Pavord ID. et al, (2024), The journal of allergy and clinical immunology. In practice

Biomarkers Associated with Lung Function Decline and Dupilumab Response in Patients with Asthma.

Journal article

Pavord ID. et al, (2024), American journal of respiratory and critical care medicine

Pioneering a paradigm shift in asthma management: remission as a treatment goal.

Journal article

Lommatzsch M. et al, (2024), The Lancet. Respiratory medicine, 12, 96 - 99

Blood eosinophils and fractional exhaled nitric oxide are prognostic and predictive biomarkers in childhood asthma.

Journal article

Bacharier LB. et al, (2024), The Journal of allergy and clinical immunology

From treatable traits to GETomics in airway disease: moving towards clinical practice.

Journal article

Papi A. et al, (2024), European respiratory review : an official journal of the European Respiratory Society, 33

How have we measured trial outcomes of asthma attack treatment? A systematic review.

Journal article

Howell I. et al, (2024), ERJ open research, 10, 660 - 2023

Fractional exhaled nitric oxide (FeNO): the future of asthma care?

Journal article

Wang K. et al, (2023), The British journal of general practice : the journal of the Royal College of General Practitioners, 73, 565 - 568

Which biologic? New findings from a real‐world study

Journal article

Lavoie G. and Pavord ID., (2023), Respirology

Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum.

Journal article

Hughes R. et al, (2023), The journal of allergy and clinical immunology. In practice, 11, 2803 - 2811

Dupilumab efficacy in high sleep disturbance management among patients with type 2 asthma.

Journal article

Maspero JF. et al, (2023), Respiratory medicine, 218

European Respiratory Society Short Guidelines for the use of as-needed ICS/formoterol in mild Asthma.

Journal article

Papi A. et al, (2023), The European respiratory journal

Load More